Arcutis Biotherapeutics(ARQT)
$27.61+0.28 (+1.02%)
ARQT
Arcutis Biotherapeutics etf exposure
$27.61
At close:+0.28 (+1.02%)
Want to see ARQT full AI Analyst Report?
ETFs with Arcutis Biotherapeutics (ARQT) Exposure
993 Followers
The following ETFs maintain exposure to Arcutis Biotherapeutics (ARQT). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
119 ETFs Hold Arcutis Biotherapeutics (ARQT)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in ARQT |
|---|---|---|---|---|---|---|
| USFMA | UBS (Irl) ETF Plc - MSCI USA Select Factor Mix UCITS ETF | $123.61M | 0.26% | <0.01% | $14.13K | <0.01% |
| DDUM | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | <0.01% | $20.85K | <0.01% |
| SPGM | SPDR Portfolio MSCI Global Stock Market ETF | $1.87B | 0.09% | <0.01% | $101.34K | <0.01% |
| GERD | L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD | $1.65B | 0.53% | <0.01% | $102.18K | <0.01% |
| K0MR | L&G Gerd Kommer Multifactor Equity UCITS ETF USD | $271.51M | 0.53% | <0.01% | $102.18K | <0.01% |
| VTI | Vanguard Total Stock Market ETF | $672.37B | 0.03% | <0.01% | $91.80M | 2.26% |
| VTHR | Vanguard Russell 3000 ETF | $4.72B | 0.06% | <0.01% | $312.88K | <0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | $93.10B | 0.03% | <0.01% | $4.27M | 0.12% |
| SPTM | SPDR Portfolio S&P 1500 Composite Stock Market ETF | $13.67B | 0.03% | <0.01% | $622.00K | 0.02% |
| IWV | iShares Russell 3000 ETF | $19.97B | 0.20% | <0.01% | $898.32K | 0.03% |
| DFAS | Dimensional U.S. Small Cap ETF | $15.23B | 0.26% | <0.01% | $1.44M | 0.04% |
| SCHB | Schwab U.S. Broad Market ETF | $43.04B | 0.03% | <0.01% | $1.80M | 0.05% |
| TILT | FlexShares Morningstar US Market Factor Tilt Index Fund | $2.14B | 0.25% | <0.01% | $88.46K | <0.01% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $41.73K | <0.01% |
| DFUS | Dimensional U.S. Equity ETF | $20.95B | 0.09% | <0.01% | $411.45K | 0.01% |
| DCOR | Dimensional US Core Equity 1 ETF | $3.58B | 0.14% | <0.01% | $711.32K | 0.02% |
| DFAC | Dimensional U.S. Core Equity 2 ETF | $47.98B | 0.17% | <0.01% | $944.17K | 0.03% |
| DFAU | Dimensional US Core Equity Market ETF | $12.56B | 0.12% | <0.01% | $61.60K | <0.01% |
| MMTM | SPDR S&P 1500 Momentum Tilt ETF | $118.75M | 0.12% | <0.01% | $546.6 | <0.01% |

Popular ETF Comparisons
ARQT ETF Exposure FAQ
What ETFs hold Arcutis Biotherapeutics stock?
Arcutis Biotherapeutics (ARQT) is currently held by 119 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to ARQT include SPDR (XBI), Simplify (PINK) and Janus Henderson (JSMD).
Which ETF has the largest exposure to ARQT?
The ETF with the largest exposure to ARQT is SPDR (XBI), with approximately $84.48M in market value exposure.
How much ARQT stock is held by ETFs?
ETFs currently hold approximately $140.57M worth of Arcutis Biotherapeutics (ARQT) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.

